Objective To analyse the outcome of patients with resectable esophageal squamous cell carcinoma after receiving three-dimensional conformal radiotherapy (3DCRT) alone, and to provide a reference for accurate prognosis prediction and better therapeutic effect. Methods A retrospective analysis was performed in 92 patients with esophageal cancer, who received radical 3DCRT in our hospital from February 2002 to July 2007, to determine the reasons for treatment failure. The recurrence, metastasis, local control, and survival were calculated by the Kaplan-Meier method;the influential factors for recurrence and metastasis were analyzed using the Cox model. Results The overall failure rate was 51%(47/92);of the 47 patients, 29 had regional recurrence, 12 had distant metastasis, and 6 had both distant metastasis and regional recurrence. In the patients with regional recurrence, there were more individuals with middle thoracic esophageal cancer than individuals with upper and lower thoracic esophageal cancers (23 vs 8 and 4, χ2=39.36,P=0.000), and there were more individuals with a partial remission than individuals with a complete remission (18 vs 7, χ2=23.44, P=0.000). In the patients with distant metastasis, there were more individuals with lower thoracic esophageal cancer than individuals with upper and middle thoracic esophageal cancers (7 vs 6 and 5, χ2=14.42, P=0.001). The multivariate analysis showed that N stage, clinical stage, and short-term efficacy were the influential factors for regional recurrence and that N stage, clinical stage, length of tumor on X-ray film, and short-term efficacy were the influential factors for distant metastasis. Conclusions After receiving 3DCRT alone, the patients with upper thoracic esophageal cancer have lower regional recurrence and distant metastasis rates than those with middle and lower thoracic esophageal cancers, and the patients with a complete remission have lower regional recurrence and distant metastasis rates than those with a partial remission. Clinical stage is still an important influential factor for regional recurrence and distant metastasis.
SHEN Wen-bin,ZHU Shu-chai,GAO Hong-mei et al. Analysis of failure patterns of three-dimensional conformal radiotherapy alone in resectable esophageal cancer[J]. Chinese Journal of Radiation Oncology, 2013, 22(3): 205-208.
[1] Herskovic A, Martz K, Al-sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with esophageal cancer. N Engl J Med,1992;326:1593-1598. [2] Minsky BD, Pajak TF, Ginsberg RJ, et al. INT0123(radiationtherapy oncology group 94-05) phase Ⅲ trial of combined-modality therapy for esophageal cancer:high-dose versus standard-dose radiation therapy. J Clin Oncol,2002,20:1167-1174. [3] Onozawa M, Nihei K, Ishikura S, et al. Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus. Radiother Oncol,2009,92:266-269. [4] Okawa T, Tanaka M, Kita-Okawa M, et al. Superficial esophageal cancer:multicenter analysis of results of definitive radiation therapy in Japan. Radiology,1995,196:271-274. [5] Hideomi Y, Kae O, Reiko W, et al. Details of recurrence sites after elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) combined with chemotherapy for thoracic esophageal squamous cell carcinoma-A retrospective analysis. Radiother Oncol,2011,98:255-260. [6] Huang SH, Lockwood G, Brierley J, et al. Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival. Int J Radiat Oncol Biol Phys,2008,71:735-740. [7] Zhao KL, Ma JB, Liu G, et al. Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma:is elective nodal irradiation necessary? Int J Radiat Oncol Biol Phys,2010,76:446-451. [8] Ma JB, Song YP, Yu JM, et al. Feasibility of involved-field conformal radiotherapy for cervical and upper-thoracic esophageal cancer. Onkologie,2011,34:599-604. [9] 沈文斌,祝淑钗,李娟,等.93例可手术切除食管癌三维适形放疗长期生存分析.中华放射肿瘤学杂志,2011,20:32-35. [10] Meguid RA, Hooker CM, Taylor JT, et al. Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer:does the pattern of recurrence differ for patients with complete response and those with partial or no response? J Thorac Cardiovasc Surg,2009,138:1309-1317. [11] Denham JW,Steigler A,Kilmurray J,et al. Relapse patterns after chemo-radiation for carcinoma of the oesophagus. Clin Oncol,2003,15:98-108. [12] Dresner SM, Griffin SM. Pattern of recurrence following oesophagectomy with two-field lymphadenectomy. Br J Surg,2000,87:1426-1433. [13] Law SYK, Fok M, Wong J. Pattern of recurrence after oesophageal resection for cancer:clinical implications. Br J Surg,1996,83:107-111. [14] Nishimaki T, Tanaka O, Ando N, et al. Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer. Ann Thorac Surg,1999,68:2059-2064. [15] Miyata H,Yamasaki M, Kurokawa Y,et al. Survival factors in patients with recurrence after curativeresection of esophageal squamous cell carcinomas. Ann Surg Oncol,2011,18:3353-3361. [16] Okabe H, Satoh S, Kato T, et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarrey:identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res,2001,61:2129-2137. [17] 沈文斌,祝淑钗,万钧,等.42例放疗后复发食管癌三维适形放疗的疗效分析.中华放射肿瘤学杂志,2010,19:111-114. [18] Fakhrian K, Gamisch N, Schuster T,et al. Salvage radiotherapy in patients with recurrent esophageal carcinoma. Strahlenther Onkol,2012,188:136-142. [19] Yano T, Muto M, Minashi K,et al. Photodynamic therapy as salvage treatment for local failure after chemoradiotherapy in patients with esophageal squamous cell carcinoma:a phase Ⅱ study. Int J Cancer,2012,131:1228-1234.
2013, Vol. 22 
